Answers are grounded in this paper and cite their sources.
The mitogen-activated protein kinase (MAPK) pathway is a vital cellular signaling cascade that viruses exploit. When activated by viruses, this pathway also initiates the host's inflammatory response. This pathway has a crucial role in viral respiratory infections, serving as a key intersection where viral replication and host inflammation are coordinated. Some viruses activate this pathway to enhance their own replication while also triggering inflammatory responses in the host. Understanding this intersection is essential because therapeutic agents could target the same pathway to inhibit both viral replication and inflammation. This perspective considers targeting the MAPK pathway as a potential way to treat viral respiratory infections by suppressing viral replication and reducing inflammation.
No takes yet. Share an insight, caveat, or question.
Tripp et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: